Loading...
Loading...
INVO| Name | Value |
|---|---|
| Revenues | 1,576.3K |
| Cost of Revenue | 1,077.2K |
| Gross Profit | 499.1K |
| Operating Expense | 1,445.5K |
| Operating I/L | -946.4K |
| Other Income/Expense | -648.3K |
| Interest Income | 0.0K |
| Pretax | -1,594.7K |
| Income Tax Expense | 1.8K |
| Net Income/Loss | -1,596.5K |
INVO Bioscience, Inc. is a commercial-stage fertility company specializing in assisted reproductive technology solutions. Its flagship product, the INVOcell, is a medical device that facilitates fertilization and early embryo development within the woman's body. The company generates revenue by providing this innovative technology to fertility clinics and healthcare facilities worldwide.
